Alzheimer’s Association International Conference 2019

Alzheimer’s Association International Conference 2019

Regular price
$10.00
Sale price
$10.00
Regular price
Sold out
Unit price
per 

Checkout securely with

Alzheimer’s Association International Conference 2019

Format:581 videos, size: 26.2 GB

Course Audience: pathologist, neurologist

02-01-01 – Sleep, Brain, and Cognition (Video MP4 Format)

02-02-01 – Alzheimer’s Disease Blood-Based Biomarkers and AD Control (Video MP4 Format)

03-02-01 – The Epidemiology of Diversity and Dementia (Video MP4 Format)

05-01-01 – Microglia in Neurodegenerative Conditions (Video MP4 Format)

05-02-01 – Precision Medicine, Population Neuroscience and Comprehensive Care Partners to Develop and Deliver Effective Prevention (Video MP4 Format)

DB-01-01 – Temporal Trajectories of In Vivo Tau and Amyloid-á Accumulation in Alzheimer’s Disease (Video MP4 Format)

DB-01-02 – Vascular Risk Factors and Multimodal Neuroimaging Biomarkers Preliminary Analyses from the Multi-Ethnic Study of Atherosclerosis (Video MP4 Format)

DB-01-03 – Global Cortical [F18]Flortaucipir Association with the Top 20 Alzheimer’s Disease Risk Genes (Video MP4 Format)

DB-01-04 – Cerebral Amyloid Angiopathy Is More Severe in Autosomal Dominant AD Cases with Cerebral Microhemorrhages (Video MP4 Format)

DT-01-01 – BAN2401 In Early Alzheimer’s Disease Neurodegeneration Biomarker Analysis From Randomized Phase 2 Study (Video MP4 Format)

DT-01-02 – Continued large amyloid PET reductions at 36 months in the gantenerumab open-label extension studies (Video MP4 Format)

DT-01-03 – Longitudinal amyloid, neurodegeneration and cognition in pre-dementia elderly individuals with different ATN profiles (Video MP4 Format)

DT-01-04 – Diagnostic performance of [18F]RO948 PET in the separation of Alzheimer’s disease (Video MP4 Format)

DT-01-05 – Temporal Lobe Quantitation of Flortaucipir PET Images May Improve Detection of Intermediate Neurofibrillary Tangle Pathology (Video MP4 Format)

DT-01-06 – Association of APOE e2 Genotype with Neuroprotection A Trans-diagnostic Study of 1557 Brains in the NACC v 10 Data Base (Video MP4 Format)

DT-02-01 – Repurposing FDG-PET as a diagnostic tool for Alzheimer’s-related TDP-43-proteinopathy (Video MP4 Format)

DT-02-02 – TOMMORROW Results from a Phase 3 Trial to Delay the Onset of MCI Due to AD and Qualify a Genetic Biomarker Algorithm (Video MP4 Format)

DT-02-03 – Open Label Extension Results from a Phase II III Trial of Intranasal Insulin (Video MP4 Format)

DT-02-04 – A Randomized Double-Blind Placebo-Controlled Phase 2A Clinical Trial of NA-831 in Patients with MCI and early onset of Alzheimer’s disease (Video MP4 Format)

DT-02-05 – A Novel Therapeutic (NTRX-07) Targeting Neuroinflammation in Alzheimer’s disease is Undergoing Phase I trials (Video MP4 Format)

DT-02-06 – A Novel Small Molecule Inhibitor of the Discoidin Domain Receptors (DDR) Reduces Tau and Amyloid-á and Improves Cognition in Models (Video MP4 Format)

EC-01-01 – The Impact of DNA Damage, Transcription Stress and Nutrition on Aging, Protein Aggregation and Neurodegeneration (Video MP4 Format)

EC-01-02 – Transposable Element Activation in Tauopathy (Video MP4 Format)

EC-01-03 – Neuronal and Glial DNA Double Strand Breaks in Early Stages of Alzheimer’s Disease (Video MP4 Format)

EC-01-04 – Age-Related Accumulation of DNA Damage in Microglia and Its Neurotoxic Consequences (Video MP4 Format)

EC-02-01 – A Fundamental Biophysical Process Contributing to Disease Mechanisms Liquid-Liquid Phase Separation of Tau (Video MP4 Format)

EC-02-02 – RNA Metabolism in Stress and Disease RNA Translation, RNA Binding Proteins, RNA Granules (Video MP4 Format)

EC-02-03 – The Role of Stress Granules and RNA Metabolism in the Pathophysiology of Tau (Video MP4 Format)

EC-02-04 – Mechanisms of Accumulation of Pathological TDP-43 In Vivo (Video MP4 Format)

EC-03-01 – Pro Side Presentations (10 minutes each) (Video MP4 Format)

EC-04-01 – Panel Discussion (Video MP4 Format)

F1-01-01 – Value of Study Partner Reports to Assess and Predict Cognitive Impairment and Decline (Video MP4 Format)

F1-01-02 – Item-Level Comparison of Participant and Study Partner Report on the Cognitive Function Index By Amyloid PET from the A4 Study (Video MP4 Format)

F1-01-03 – Online Study Partner-Reported Subjective Decline Is Associated with á-Amyloid and Clinical Diagnosis (Video MP4 Format)

F1-01-04 – Why Is the Study Partner Requirement a Barrier to Recruitment in Preclinical Alzheimer’s (Video MP4 Format)

F1-02-01 – Subthreshold Amyloid Accumulation Does It Predict Memory Decline (Video MP4 Format)

F1-02-02 – Biological Consequences of Subthreshold Amyloid Accumulation (Video MP4 Format)

F1-02-03 – Effects of Amyloid Accumulation on Neurocognitive Performance in Healthy Middle-Aged and Older Adults (Video MP4 Format)

F1-02-04 – Multimodal Evidence for Early Amyloid Accumulation (Video MP4 Format)

F1-03-01 – CSF Biomarkers Related to Neurodegeneration As Predictors of Cognitive Progression in MCI and Elderly Controls (Video MP4 Format)

F1-03-02 – The at(N) Framework in the Wisconsin Registry for Alzheimer’s Prevention Evidence from PET Imaging (Video MP4 Format)

F1-03-03 – Distinct Contributions of Baseline and Longitudinal Amyloid PET Measures to Memory (Video MP4 Format)

F1-03-04 – Aá-Positivity Predicts Cognitive Decline but Cognition Also Predicts Progression to Aá-Positivity (Video MP4 Format)

F1-04-01 – Frequency of Subjective Cognitive Decline Criteria in Stage 2 of the New NIA-AA Framework (Video MP4 Format)

F1-04-02 – Harmonizing Subjective Cognitive Decline Measurements across 19 International Cognitive Aging Studies (Video MP4 Format)

F1-04-03 – ATN Biomarker Model As a Determinant of Cognitive Decline and Incident Clinical Progression in Subjective Cognitive Decline (Video MP4 Format)

F1-04-04 – The SCD-Well Randomized Controlled Trial Effects of a Mindfulness-Based Intervention Versus Health Education (Video MP4 Format)

F1-05-01 – Lab-Related Pre-Analytical Factors Influencing Plasma Amyloid Beta Concentrations (Video MP4 Format)

F1-05-02 – Patient-Related Pre-Analytical Factors Influencing Plasma Amyloid Beta Concentrations (Video MP4 Format)

F1-05-03 – The 1946 Cohort – Relationships between Cerebral Amyloid Pathology Using Two Independent Methods for Plasma Amyloid Beta Measurement (Video MP4 Format)

F1-05-04 – The Global Alzheimer’s Association Round Robin Study on Plasma Amyloid Beta Methods (Video MP4 Format)

F1-06-01 – Sleep-Wake Behavior in the 4Repeat Tauopathy- Progressive Supranuclear Palsy (Video MP4 Format)

F1-06-02 – Neurobiological Basis of Sleep and Wake Dysfunction in AD and Other Tauopathies The Role of the Neuromodulatory System (Video MP4 Format)

F1-06-03 – Altered Sleep-Wake Mechanisms in Neurodegenerative Disease Similarities and Difference between Lewy Body Disease and Narcolepsy (Video MP4 Format)

F1-06-04 – Panel Discussion (including the audience brainstorming on the best ways to address gaps) (Video MP4 Format)

F1-07-01 – Astroglial and Microglial Modulation of Neural Functions in Models of Alzheimer’s Disease (Video MP4 Format)

F1-07-03 – Alzheimer’s Susceptibility Genes Implicate Microglial Activity (Video MP4 Format)

F1-07-04 – Using Human iPSC Models to Probe TREM2 Function (Video MP4 Format)

F1-08-01 – Ethnic Differences in Cognition and Age in People Diagnosed with Dementia A Study of Electronic (Video MP4 Format)

F1-08-02 – Using Racial Ethnic Comparisons to Evaluate Unmeasured Confounding (Video MP4 Format)

F1-08-03 – The Effect of Ethnicity on the Sensitivity of General Hospital Dementia Records Cohort Study Using English Electronic Health Records (Video MP4 Format)

F1-08-04 – Panel Discussion (Video MP4 Format)

F2-01-01 – Neurodevelopmental Differences and Environmental Insults Inversely Correlate with Age of Onset in Alzheimer’s Disease (Video MP4 Format)

F2-01-03 – Am I the Right Way up Investigating Balance Problems in Posterior Cortical Atrophy (Video MP4 Format)

F2-01-04 – Paradoxical Aging in Alzheimer’s Disease (Video MP4 Format)

F2-02-01 – Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer’s Disease (Video MP4 Format)

F2-02-02 – Understanding the Role of SORL1 and Endosomal Network Dysfunction in Alzheimer’s Disease (Video MP4 Format)

F2-02-03 – Alzheimer’s Disease Modeling and Drug Screening Using Patients-Derived iPSCs with Different ApoE Genotypes (Video MP4 Format)

F2-02-04 – Targeting Aberrant Cholesterol Metabolism in Alzheimer’s Disease; Drug Discovery in iPSC-Derived Neurons. (Video MP4 Format)

F2-03-01 – Clinical Meaningfulness of Short-Term Cognitive Decline on the Preclinical Alzheimer’s … (Video MP4 Format)

F2-03-02 – Optimizing Cognitive Outcomes for Biomarker Positive Individuals at Different Clinical Stages of Alzheimer’s Disease According (Video MP4 Format)

F2-03-03 – Adcoms A Sensitive Measure of Disease Progression in Early AD Supporting Better Development Decisions (Video MP4 Format)

F2-03-04 – Assessing Clinical Meaningfulness of Outcomes in the Alzheimer’s Prevention Initiative Generation Program (Video MP4 Format)

F2-04-01 – Neuropathology of VCID A Classical Landscape (Video MP4 Format)

F2-04-02 – Neuropathology Big Data. It’s All VCID (Video MP4 Format)

F2-04-03 – Digital Molecular Pathology. Axonal Damage and Small Vessel Disease (Video MP4 Format)

F2-04-04 – Leveraging Neuropathology to Integrate with RNA and Other Omics (Video MP4 Format)

F2-05-01 – Sleep Duration over 28 Years and Grey Matter Volumes A Prospective Cohort Study (Video MP4 Format)

F2-05-02 – How Does Sleep-Wake Disturbance Relate to Neuropsychological and Neuroimaging Markers in Older People at Risk for Dementia (Video MP4 Format)

F2-05-03 – Sleep Medication Use and Risk of Dementia in a Biracial Cohort of Older Adults (Video MP4 Format)

F2-05-04 – Slow Wave Sleep Enhancers As a Potential Therapeutic Approach in Delaying Cognitive Decline in Alzheimer’s Disease (Video MP4 Format)

F2-06-01 – Major Differences between the Self-Assembly, Seeding Behavior, and Interaction with Modulators (Video MP4 Format)

F2-06-02 – Trafficking of Tau Oligomers through the Plasma Membranes of Neurons and Astrocytes Is Critical for Their Synaptotoxicity (Video MP4 Format)

F2-06-03 – Amyloid á-Protein Oligomers Promote the Uptake of Tau Fibril Seeds Potentiating … (Video MP4 Format)

F2-06-04 – Polymorphism and Toxic Interactions between Soluble Amyloid Oligomers and Tau (Video MP4 Format)

F2-07-01 – Blood Amyloid-Beta Predicts Amyloid PET Conversion (Video MP4 Format)

F2-07-02 – Recent Findings of Novel Blood Components Amyloid-Beta Measures (Video MP4 Format)

F2-07-03 – Fully Automated Plasma Assays As Screening Tests for Early Alzheimer-Related á-Amyloid (Video MP4 Format)

F2-07-04 – Plasma Amyloid Beta 1-42 and 1-40 Measured By a Novel Simoa Assay As a Diagnostic Tool (Video MP4 Format)

F2-08-01 – Sleep Timing and Risk of Dementia Among Chinese Elderly in an Urban Community (Video MP4 Format)

F2-08-02 – Local Slow Wave Measures during Nrem Slow Wave Sleep Accurately Track á-Amyloid Status (Video MP4 Format)

F2-08-03 – Effect of Sleep on CSF Tau and p-Tau (Video MP4 Format)

F2-08-04 – Obstructive Sleep Apnea, Cognition and AD Neurodegeneration. (Video MP4 Format)

F3-01-01 – The Diagnostic Framework for Alzheimer’s Disease (Video MP4 Format)

F3-01-02 – Capturing Cognitive Impairment at the Preclinical Stage of Alzheimer’s Disease Using Digital Technology (Video MP4 Format)

F3-01-03 – The Integrated Cognitive Assessment – Employing Artificial Intelligence for the Detection of Cognitive Impairment (Video MP4 Format)

F3-01-04 – Panel Discussion (Video MP4 Format)

F3-02-01 – The Effect of Race on Driving Performance, Self-Reported and Naturalistic Driving Behavior Among Older Adults (Video MP4 Format)

F3-02-02 – The Stress and Resilience in Dementia (STRIDE) Study Social-Biological Dimensions of ADRD Risk, Disparity, and Resilience (Video MP4 Format)

F3-02-03 – Creating Dementia-Friendly Faith Villages to Support African American Families (Video MP4 Format)

F3-02-04 – It’s Tied to a Purpose A Culturally Celebratory Approach to Motivate Physical and Social Activity Among African Americans (Video MP4 Format)

F3-03-01 – Unveiling the Neural Correlates of Cognitive and Functional Impairments in Ageing and Dementia Relying on Mobile EEG Technologies (Video MP4 Format)

F3-03-02 – Studying the Effects of Repetitive Paired Associative Stimulation on Dlpfc Plasticity (Video MP4 Format)

F3-03-03 – Replicating Lab Electrophysiology with Older Users in the Home, Using Gamified Dry EEG (Video MP4 Format)

F3-03-04 – Exploration of EEG Event-Related Potentials in a Memory Disorders Clinic (Video MP4 Format)

F3-04-01 – Barriers and Facilitators for Retaining Independence at Home from a UK Multi- Stakeholder Perspective (Video MP4 Format)

F3-04-02 – Inequalities in Care Provision for People with Dementia from Different Ethnic Minority Groups (Video MP4 Format)

F3-04-03 – Co-Designing a Training Programme for Paid Home Carers to Deliver Dementia Specific Care to People at Home (Video MP4 Format)

F3-04-04 – Stakeholder Perspectives on How the Home Care Sector Can Support People to Live Well with Dementia. (Video MP4 Format)

F3-05-01 – Vascular Cognitive Disorders in L M I Cs Challenges and Opportunities in Studying Diverse Populations (Video MP4 Format)

F3-05-02 – Vascular Risk Factors for a D R D in Latin America A Focus on the Caribbean (Video MP4 Format)

F3-05-03 – Vascular Risk Factors and Multimodal Neuroimaging Biomarkers Preliminary Analyses (Video MP4 Format)

F3-05-04 – White Matter Hyperintensities and Cognition The Moderating Role of Quality of Education in a Multiracial Community Sample (Video MP4 Format)

F4-01-01 – Plasma Test for Amyloid Risk Screening The C2N sponsored PARIS Add-on Study to IDEAS (Video MP4 Format)

F4-01-02 – Increasing the Impact of the Ideas Study Using Brain Health Registry Online Data Collection (Video MP4 Format)

F4-01-03 – Caregivers’ Reactions and Experiences Imaging Dementia-Evidence for Amyloid Scanning (CARE IDEAS) (Video MP4 Format)

F4-01-04 – Amyloid Neuroimaging and Genetics Initiative A Resource for Investigators (Video MP4 Format)

F4-01-05 – Racial and Ethnic Differences in Amyloid PET Positivity in the IDEAS Study (Video MP4 Format)

F4-02-01 – Trials and Tribulations of Tau PET Imaging (Video MP4 Format)

F4-02-03 – Tau Fluid Biomarkers State-of-the-Art and Novel Findings in AD and Primary Tauopathies (Video MP4 Format)

F4-02-04 – CSF and PET Measures for Tau in Different Stages of Alzheimer’s Disease (Video MP4 Format)

F4-03-01 – Neuropathological Features Underlying Ante-Mortem Cholinergic Basal Forebrain and Medial … (Video MP4 Format)

F4-03-02 – Neuropathological Substrate of Imaging Biomarkers – Validating Neuroimaging Biomarkers in AD (Video MP4 Format)

F4-03-03 – Selectivity of PET Amyloid Imaging Ligands in the Alzheimer’s Disease Neuropathology Spectrum (Video MP4 Format)

F4-03-04 – Autopsy Validation of Amyloid and Tau PET in Clinical Populations (Video MP4 Format)

F4-04-01 – Trial Design, Data Sharing Risk Mitigation, and Baseline Clinical and Cognitive Data from the API (Video MP4 Format)

F4-04-02 – Age-Related Changes in Baseline Cognitive Measures in Unimpaired PSEN1- E280A (Video MP4 Format)

F4-04-03 – Relationships between Baseline Brain Imaging Biomarker Measurements (Video MP4 Format)

F4-04-04 – Association between Cerebral Amyloidosis and Worse Cognitive Performance (Video MP4 Format)

F4-05-02 – Comparison of Variables Associated with CSF Neurofilament, Total-Tau, and Neurogranin in a Community-Based Study (Video MP4 Format)

F4-05-03 – Blood Neurofilament Light (NFL) – a Sensitive but Slow-Release Biomarker (Video MP4 Format)

F4-05-04 – Serum Neurofilaments As Therapy Response Markers in Neurodegenerative Diseases (Video MP4 Format)

F4-06-01 – The Rowland Universal Dementia Assessment Scale A Cross-Cultural Screening Measure for Dementia Clinical Trials (Video MP4 Format)

F4-06-02 – Building Cognitive Reserve in Resource-Limited Settings Evidence from the Health and … (Video MP4 Format)

F4-06-03 – Staging of Cognitive Impairment and Dementia in Low-Educated Elderly (Video MP4 Format)

F4-06-04 – Detecting Dementia in Older, Ethnically Diverse Residents in Rural Subsidized Housing (Video MP4 Format)

F5-01-01 – The Role of Lipid Mediators in Neuroinflammation and Preoperative Neurocognitive Disorders (Video MP4 Format)

F5-01-03 – Neurofilament Light in a Mexican American Cohort (Video MP4 Format)

F5-01-04 – Inflammation As a Potential Shared Mechanism for Postoperative Delirium and Long-Term Cognitive Decline in Older Adults Undergoing (Video MP4 Format)

F5-02-01 – The Interaction of Genetic Admixture and ApoE4. Implications for Cognitive Decline in Alzheimer Disease. (Video MP4 Format)

F5-02-02 – Higher Literacy Associates with Better Brain Structure and Cognition in Middle-Aged Individuals (Video MP4 Format)

F5-02-03 – Factors Impacting Loss-to-Follow-up from a Memory Care Center A Study of Potential Palliative Care Needs (Video MP4 Format)

F5-02-04 – Advanced Directive and POLST Utilization in Decedents with Dementia Previously Seen at a Memory Center (Video MP4 Format)

FTS1-01-01 – Introduction to LATE (Video MP4 Format)

FTS1-01-02 – The Pathology of LATE (Video MP4 Format)

FTS1-01-03 – Public Health Impact and Cognition Associated with LATE Neuropathology (Video MP4 Format)

FTS1-01-04 – LATE Biomarkers and Impact on Alzheimer’s Prevention and Treatment Trials (Video MP4 Format)

FTS1-01-05 – Panel Discussion LATE into the World of Alzheimer’s Dementia Nomenclature to Advance Science amidst Multiple Stakeholders (Video MP4 Format)

FTS2-01-01 – Panel Presentation (Video MP4 Format)

FTS3-01-01 – Umibecestat (CNP520) Is Not Associated with Changes in Hippocampal Morphology (Video MP4 Format)

FTS3-01-02 – Subgroup Populations in Amaranth, a Randomized Phase 23 Study in Early Alzheimer’s Disease with Lanabecestat (Video MP4 Format)

FTS3-01-03 – Performance on Exploratory Efficacy Variables in Amaranth, a Randomized Phase 23 (Video MP4 Format)

FTS3-01-04 – Final Efficacy, Safety and Biomarker Results of the Phase 2b3 (Video MP4 Format)

FTS3-01-05 – Further Analyses of Cognitive Outcomes in the Apecs Phase-3 Trial of Verubecestat in Prodromal AD (Video MP4 Format)

FTS3-01-06 – Current Update on Elenbecestat in Alzheimer”s Disease (Video MP4 Format)

FTS3-01-07 – Panel Discussion (Video MP4 Format)

FTS5-01-02 – Correlating Cognitive Outcomes with Patient Specific Biomarkers in Alzheimer’s Disease (Video MP4 Format)

FTS5-01-03 – A Pharmacokinetic Pharmacodynamic Evaluation of Imaging Biomarkers of Alzheimer”s Disease (Video MP4 Format)

FTS5-01-04 – The Amyloid Hypothesis Latest Update in the Context of Recent Trial Evidence (Video MP4 Format)

IC-01-01 – [Alzheimer’s Imaging Consortium] Plenary Session What Have We Learned (Video MP4 Format)

IC-02-01 – Grey Matter Connectivity Trajectories across the Alzheimer’s Disease Continuum and Associations with Cognitive Decline (Video MP4 Format)

IC-02-02 – Longitudinal Evaluation of Tau Propagation Using [18f]MK-6240 (Video MP4 Format)

IC-02-03 – Mild Cognitive Impairment Progressing to Dementia with Lewy Bodies Regional Atrophy Rates and Relationship to AV-1451 Uptake (Video MP4 Format)

IC-02-04 – Novel Measures of Longitudinal Change in Medial Temporal Lobe Subregions Discriminate Preclinical Alzheimer’s Disease (Video MP4 Format)

IC-02-05 – Gender Differences in the Association between Longitudinal Brain Changes and Baseline Levels of CSF (Video MP4 Format)

IC-03-01 – Plenary Session Preclinical Cognitive Decline Is Related to Tau and Amyloid Imaging Profiles in a Risk-Enriched Cohort (Video MP4 Format)

IC-04-01 – The Search for Pathologically Valid Imaging Biomarkers – AD Pathology Comes Not Alone (Video MP4 Format)

IC-04-02 – Ante-Mortem Volume Loss Mirrors TDP43 Staging in Non-FTLD Older Adults (Video MP4 Format)

IC-04-03 – Utility of MRI in Detection of Atrophy in Hippocampal Sclerosis of Aging (Video MP4 Format)

IC-04-04 – Iron, Neurodegeneration, Tau, and Amyloid in Patients with Alzheimer’s Disease. (Video MP4 Format)

IC-04-05 – Cross-Sectional and Longitudinal Medial Temporal Lobe Subregional Atrophy in Suspected … (Video MP4 Format)

IC-05-01 – Debate MRI Versus PET Which Imaging Modality Provides the Best Biomarker and for Which Purpose (Video MP4 Format)

IC-06-01 – Assessment of Longitudinal Amyloid Load Change in Down Syndrome (Video MP4 Format)

IC-06-02 – Associations between Aá and Tau in Adults with Down Syndrome (Video MP4 Format)

IC-06-03 – Spatial Associations of Aá with Tau Deposition in Down Syndrome (Video MP4 Format)

IC-06-04 – Sleep, Cognition, and á-Amyloid in Adults with Down Syndrome (Video MP4 Format)

IC-06-05 – Baseline Amyloid (18F-AV-45 PET) Distributions By Consensus Diagnosis from the Biomarkers (Video MP4 Format)

IC-07-01 – Functional Brain Architecture Predicts Longitudinal Tau Spreading in Alzheimer’s Disease (Video MP4 Format)

IC-07-02 – What Can Structural MRI Tell about aTN Staging (Video MP4 Format)

IC-07-03 – Biomarkers for Capturing Amyloid Independent Effects of Vascular Health on Cognitive Decline (Video MP4 Format)

IC-07-04 – A Topographic Imaging Biomarker of TDP43 Pathology in Amnestic Dementia Based on Autopsy-Derived FDG-PET Patterns (Video MP4 Format)

IS-01 – ISTAART Student Workshop Series Final Title TBD (Video MP4 Format)

IS-02 – ISTAART Student Workshop Series Final Title TBD (Video MP4 Format)

IS-03 – ISTAART Student Workshop Series Final Title TBD (Video MP4 Format)

O1-01-01 – Integrative Proteomics Links Cerebrospinal Fluid Biomarkers to Pathological Networks in Alzheimer’s Disease Brain (Video MP4 Format)

O1-01-02 – Tau Phosphorylation Rates Change from Brain to Cerebrospinal Fluid and Are Differentially Affected By Alzheimer Disease (Video MP4 Format)

O1-01-03 – Plasma Aá42 Aá40 Predicts Hippocampal Atrophy (Video MP4 Format)

O1-01-04 – Identification and Biological Characterization of Extracellular Vesicle Proteins for Propagation and Spread of Tau (Video MP4 Format)

O1-01-05 – Proteomic Assessment of Synapses with Rich Associated Clinical Data Highlight Potential Targets (Video MP4 Format)

O1-01-06 – Neuron-Glia Interaction Markers in Predementia Alzheimer’s Disease (Video MP4 Format)

O1-02-01 – Self-Reported Hearing and Vision Impairment Predicts Dementia in the Oldest Old Pooled Analysis (Video MP4 Format)

O1-02-02 – The Impact of Hearing Loss and Sensory Intervention on the Risk of Progression to Dementia in Mild Cognitive Impairment Cases (Video MP4 Format)

O1-02-03 – Age-Related Hearing Loss and Cognitive Decline in the General Population (Video MP4 Format)

O1-02-04 – Failure to Identify Particular Odours Predicts Future Dementia and Mortality (Video MP4 Format)

O1-02-05 – Dual Sensory Impairment in Older Adults and Risk of Dementia and Alzheimer’s Disease (Video MP4 Format)

O1-02-06 – Association between the Olfactory Identification Ability and Cognitive Function in Non-Demented Elderly (Video MP4 Format)

O1-03-01 – Misfolding and Early Aggregation of Amyloid á42 Protein Critical Role of Membranes (Video MP4 Format)

O1-03-02 – Mechanistic Mathematical Model of the Impact of Anti-Amyloid Beta Drugs and BACE Inhibitors in Alzheimer’s Disease. (Video MP4 Format)

O1-03-03 – Predicting Brain Amyloidosis Using Peripheral Blood-Based Gene Expression and Early Stage Neurodegeneration Biomarkers (Video MP4 Format)

O1-03-04 – Cortical Neurons and Cerebral Organoids from APP and PSEN1 Mutation Carriers Reveal … (Video MP4 Format)

O1-03-05 – Induction of Different Brain Pathology in Mice Treated with Two Misfolded Aá Conformers (Video MP4 Format)

O1-03-06 – Pyroglutamation of Aáx-42 and Aá1-40 Deposition Underlie Amyloid Plaque Polymorphism (Video MP4 Format)

O1-04-01 – A Topographic Imaging Biomarker of TDP43 Pathology in Amnestic Dementia Based on Autopsy-Derived FDG-PET Patterns (Video MP4 Format)

O1-04-02 – Early and Late-Onset Alzheimer’s Disease and Suspected Non-Alzheimer Pathophysiology within the aTN Framework (Video MP4 Format)

O1-04-03 – Visually-Rated Structural MRI Profiles in Neuropathologically-Confirmed Chronic Traumatic Encephalopathy (Video MP4 Format)

O1-04-04 – Metabolic Brain Pattern of Creutzfeldt-Jakob Disease and Its Biological Significance (Video MP4 Format)

O1-04-05 – Pathologic Associations of FDG PET in Lewy Body Disease (Video MP4 Format)

O1-04-06 – Cognitive Impairment in in Older Adults with MCI Due to SNAP May be Partially Attributable to Comorbid Conditions (Video MP4 Format)

O1-05-01 – Public Involvement in Research Collaborations in Dementia Care (Video MP4 Format)

O1-05-02 – Nothing about Us without Us Creating the First Canadian Charter of Rights for People with Dementia (Video MP4 Format)

O1-05-03 – Wrap Around Services to Older Adults with Dementia Collaboration, Education, and Prevention (Video MP4 Format)

O1-05-04 – Reaching Individuals Living with Alzheimer’s Disease or Related Dementias from Minority Population (Video MP4 Format)

O1-05-05 – Promoting Dementia Awareness in African American Communities Impact of the Dementia Caring Community Outreach Model (Video MP4 Format)

O1-05-06 – Aging with Pride, IDEA Lessons Learned from the First Tested Clinical Intervention Addressing Dementia (Video MP4 Format)

O1-06-01 – Impact of Healthy Lifestyle Factors on the Risk of Alzheimer’s Dementia; Findings from Two Prospective Cohort Studies (Video MP4 Format)

O1-06-02 – Genetic Risk, Lifestyle and Dementia (Video MP4 Format)

O1-06-03 – Characterization of Cognitive Performance, Gray Matter Volume and White Matter Microstructure (Video MP4 Format)

O1-06-04 – Association between Hypertension and Alzheimer’s Disease and Related Causes of Dementia A Pathways Analysis in the Memento Cohort (Video MP4 Format)

O1-06-05 – Higher Education Provides Resilience Against Deteriorative Effects of Higher Middle Age Body Mass Index on Old Age Cognitive Functioning (Video MP4 Format)

O1-06-06 – The Compensatory Role of Physical Activity on the Association between the … (Video MP4 Format)

O1-07-01 – Longitudinal Evaluation of the Natural History of Aá in Plasma and Brain (Video MP4 Format)

O1-07-02 – Longitudinal Associations between Plasma Nfl and Voxel-Based Morphometry in Alzheimers Disease (Video MP4 Format)

O1-07-02 – Longitudinal Associations between Plasma Nfl and Voxel-Based Morphometry in Alzheimer’s Disease (Video MP4 Format)

O1-07-03 – Longitudinal Plasma Neurofilament Light Is Associated with Rates of Regional Brain Atrophy in Alzheimer’s Disease (Video MP4 Format)

O1-07-04 – CSF Biomarkers of Amyloid, Tau and Synaptic Damage (Neurogranin, SNAP25) and Interneuron-Dependent (Video MP4 Format)

O1-07-05 – Longitudinal Effect of Biological Variables on Plasma NFL and t-Tau Concentrations on Subjective Memory Complainers (Video MP4 Format)

O1-07-06 – Prevalence and Longitudinal Clinical Outcomes of Alzheimer’s ATN Biomarker Profiles A Longitudinal Study (Video MP4 Format)

O1-08-01 – Therapeutic Targeting of TREM2 By an Activating Antibody Ameliorates Amyloid-Beta Deposition (Video MP4 Format)

O1-08-02 – Development of TREM2 Agonistic Antibodies to Treat Alzheimer’s Disease (Video MP4 Format)

O1-08-03 – Targeting NLRP3 Inflammasome with a Novel Inhibitor for Alzheimer’s Disease (Video MP4 Format)

O1-08-04 – Preclinical Development of TREM2 Agonist Antibody (AL002) in Cynomolgus Monkeys (Video MP4 Format)

O1-08-05 – Anti-Inflammatory Effects of SM07883, a Novel, Potent, and Selective Oral DYRK1A Inhibitor in Neurodegenerative Mouse Models (Video MP4 Format)

O1-09-01 – Estimating Years from Clinical Symptom Onset for Sporadic Alzheimer Disease How Far Are We (Video MP4 Format)

O1-09-02 – Two-Period Linear Mixed Effects Primary Analysis Model for Clinical Trials with Run-in Data for Alzheimer Disease (Video MP4 Format)

O1-09-03 – Sex Is Not an Important Predictor of Change in Alzheimer’s Clinical Trial Outcomes (Video MP4 Format)

O1-09-04 – Applying Polygenic Hazard Scores to Enrich Clinical Trial Study Populations of Those at Risk of Alzheimer’s Disease Dementia (ADD) (Video MP4 Format)

O1-09-05 – Sexual Dimorphism in Plasma Beta-Secretase 1 Concentrationsin Cognitively Normal Individuals at Risk for AD (Video MP4 Format)

O1-09-06 – Addressing Polypharmacy Issues in an Elderly Population with Cognitive Impairment, Using a Precision-Medicine Platform (Video MP4 Format)

O1-10-01 – Assessing Global and Regional Aá-Amyloid Deposition in the Brain with Multiple Aá-Tracers Using the Centiloid Scale (Video MP4 Format)

O1-10-02 – Longitudinal Analysis of Multivariate Patterns of Amyloid Deposition Reveals Consistent Stages of Amyloidosis across Studies and Tracers (Video MP4 Format)

O1-10-03 – Anatomical Staging of Beta-Amyloid Accumulation Based on Longitudinal Assessment of Globally PIB Negative Adults (Video MP4 Format)

O1-10-04 – Centiloid Cut-Off Values for Optimal Agreement between Amyloid PET and CSF Core AD Biomarkers (Video MP4 Format)

O1-10-05 – Longitudinal Investigation of Concordant and Discordant Amyloid CSFPET Biomarkers Reveals CSF-First (Video MP4 Format)

O1-10-06 – Centiloid Scale in Practice Effect of Different Suvr Reference Regions and Comparison of Centiloid Cut-Offs (Video MP4 Format)

O1-11-01 – Carer’s Appraisal of People with Dementia’s Performance of Daily Tasks What Is the Role of the Carer Management Style (Video MP4 Format)

O1-11-02 – Estimated Impact of Diagnostic Tools for Primary Care Settings on Demand for Specialist Visits for Patients with Prodromal Alzheimer’s Disease (Video MP4 Format)

O1-11-03 – Development and Validation of the Electronic Health Record Risk of Alzheimer’s and Dementia Assessment Rule (eRADAR) (Video MP4 Format)

O1-11-04 – The Acceptance of Using Virtual Reality in a Cognitive Stimulation Activity in Older Adults. a Multicenter Randomized Controlled Trial. (Video MP4 Format)

O1-11-05 – Effects of a Distraction Method Using a Social Robot on Pain and Anxiety Management in Major Neurocognitive Disorders (Video MP4 Format)

O1-11-06 – High Intensity Telemedicine Reduces Emergency Department Use By Older Adults with Dementia in Senior Living Communities (Video MP4 Format)

O2-01-01 – Brooklyn Cognitive Impairments in Health Disparities Pilot Study (Video MP4 Format)

O2-01-02 – Caregiver Distress from Behavioral Disturbances in Persons with Autosomal Dominant Alzheimer’s Disease Mutations (Video MP4 Format)

O2-01-03 – Abide Delphi Study Topics to Discuss in Diagnostic Consultations in Memory Clinics (Video MP4 Format)

O2-01-04 – Individualized Non-Pharmacological Services Integrating Geriatric Health and Technology (INSIGHT) (Video MP4 Format)

O2-01-05 – Designing a Better Visit Touch Screen Apps for People Living with Dementia and Their Visitors (Video MP4 Format)

O2-01-06 – New York State’s Public Health Approach to Alzheimer’s Disease (Video MP4 Format)

O2-02-01 – Different CSF Total and Phosphorylated Tau, but Not Aá, in Older and Younger African Americans and Whites (Video MP4 Format)

O2-02-02 – Comparison of Cognitive, Biomarker and Neuroimaging Characteristics of T+N+ Patients (Video MP4 Format)

O2-02-03 – Stepwise Patient Selection for Amyloid Measurements (Video MP4 Format)

O2-02-04 – CSF Biomarkers in Down Syndrome (Video MP4 Format)

O2-02-05 – Predicting Brain Age As a Biomarker for Risk of Dementia (Video MP4 Format)

O2-02-06 – Cerebrospinal Fluid Based Biomarker Evidence of Amyloidogenesis in Dementia with Lewy Bodies Depends upon ApoE-e4 Carrier Status (Video MP4 Format)

O2-03-01 – Amyloidosis Induces Early Metabolic Reorganization (Video MP4 Format)

O2-03-02 – Derivation and Potential Utility of an Aá PET Imaging Based Weighting Factor for Estimation of Aá Load (Video MP4 Format)

O2-03-03 – Predictors of á-Amyloid Positivity in Cognitively Impaired Patients. Data from the (Video MP4 Format)

O2-03-04 – Defining Amyloid PET Positivity – What If the Coin Had More Than 2 Sides (Video MP4 Format)

O2-03-05 – Prevalence of Clinically Vs. Biologically Defined Alzheimer’s Spectrum Entities Using the National Institute on Aging (Video MP4 Format)

O2-03-06 – Heterogeneity of Amyloid Deposition Pattern Among Amyloid-Positive Cognitively Impaired Individuals (Video MP4 Format)

O2-04-01 – The Role of Astrocytic a7 Nicotinic Acetylcholine Receptors in Neuroinflammation-Mediated Cognitive Impairment (Video MP4 Format)

O2-04-02 – Visualizing Brain Astrocytes – Characterization of 3H-BU99008, an Imidazoline 2 Receptor Ligand, in Human AD Brain (Video MP4 Format)

O2-04-03 – Astrocytosis and Microgliosis Are Early Features of Conditional Mouse Models of … (Video MP4 Format)

O2-04-04 – A Novel Transgenic Rat Model for Mixed Dementia (Video MP4 Format)

O2-04-05 – Predictive Network Analysis Identifies Microglial-Specific Therapeutic Targets for Phagosome (Video MP4 Format)

O2-04-06 – Polymicrobial Infection Exacerbates Neuroinflammation and Worsens Alzheimer’s Associated (Video MP4 Format)

O2-05-01 – Cerebrospinal Fluid Synaptic Vesicle Glycoprotein 2A in Alzheimer’s Disease (Video MP4 Format)

O2-05-02 – Combining Omics and Cognitive Tests Data from the Insight Pre-AD Study, Artificial Intelligence Technology (Video MP4 Format)

O2-05-03 – Characterization and Transfer of a Novel Plasma Aá1-42Aá1-40 Simoa Assay for … (Video MP4 Format)

O2-05-04 – Plasma pTau181 Levels Reflect [18F]AV1451 Tau PET Uptake across the Tauopathy Spectrum (Video MP4 Format)

O2-05-05 – Correlation of CSF Phospholipids and Alzheimer’s Disease Neuropathology (Video MP4 Format)

O2-05-06 – Diagnosing Alzheimer’s Disease through Detection of Tau Protein in Human Blood Using Ultrasensitive (Video MP4 Format)

O2-06-01 – How Do People with Young-Onset Dementia and Their Family Make Decisions and Plan for the Future in Relation (Video MP4 Format)

O2-06-02 – Financial, Legal, and Social Decision-Making in Early-Onset Alzheimer’s Disease (Video MP4 Format)

O2-06-03 – Patterns of Dyadic Appraisal of African American Persons with Dementia Decision-Making and Quality of Life (Video MP4 Format)

O2-06-04 – Ethical Issues Raised By the Introduction of Artificial Companions to Older Adults with Cognitive Impairment A Call for Empowerment (Video MP4 Format)

O2-06-05 – Preliminary Results from the Study of Knowledge and Reactions to Apoe Testing (SOKRATES 2) (Video MP4 Format)

O2-07-01 – Sleep Quality and Beta-Amyloid Deposition in Recently Menopausal Women Participating in the Kronos Early Estrogen Prevention Study (KEEPS) (Video MP4 Format)

O2-07-03 – Differential Influence of Aging and Alzheimer’s Disease on Sleep and Rest-Activity Rhythms over Entire Adult Life (Video MP4 Format)

O2-07-04 – High Compliance, Continuous Long-Term Home Monitoring of Sleep Activity in Diverse Populations Differentiates Lower (Video MP4 Format)

O2-07-05 – Obstructive Sleep Apnea Severity and Brain Integrity in Ageing A Multimodal … (Video MP4 Format)

O2-07-06 – Sleep-Wake Cycle and 2-Year Changes of Alzheimer’s Disease Neuroimaging Biomarkers and Cognition (Video MP4 Format)

O2-08-01 – Ante-Mortem Volume Loss Mirrors TDP43 Staging in Non-FTLD Older Adults (Video MP4 Format)

O2-08-02 – Early Life Foreign Language Instruction and Late Life Amyloid and Tau Deposition (Video MP4 Format)

O2-08-03 – Long-Term Exposure to Air Pollution and Dementia A Large Clinicopathological Study (Video MP4 Format)

O2-08-04 – Phenotypic Heterogeneity in Familial Alzheimer’s Disease and Associations with Cerebral Amyloid Angiopathy (Video MP4 Format)

O2-08-05 – Pathological Drivers of Neurodegeneration in Suspected Non-Alzheimer’s Pathophysiology (Video MP4 Format)

O2-08-06 – CA2 Neurofibrillary Degeneration and Asymmetry in Primary Age-Related Tauopathy (Video MP4 Format)

O2-09-01 – The Natural History of Alzheimer’s Disease in Down Syndrome (Video MP4 Format)

O2-09-02 – Biphasic Trajectory of Changes for Cortical Thickness and Cortical Mean Diffusivity in Autosomal Dominant Alzheimer’s Disease (Video MP4 Format)

O2-09-03 – Effects of Gene Mutation and Disease Progression on the Structure and Function of Three Cortico-Subcortical Neural Circuits (Video MP4 Format)

O2-09-04 – Single-Subject Grey Matter Networks Deteriorate 12 Years before Dementia (Video MP4 Format)

O2-09-05 – Longitudinal F-AV-1451 Tau PET in Familial Alzheimer’s Disease (Video MP4 Format)

O2-09-06 – Trajectory of Lobar Atrophy in Asymptomatic and Symptomatic Grn Mutation Carriers (Video MP4 Format)

O2-10-01 – Stop-Gain and Non-Synonymous Variants in Novel Genes of an Immune Co-Regulatory Network (Video MP4 Format)

O2-10-02 – Whole Exome Sequencing Analysis in Early Onset Alzheimer Reveals Novel Candidate Genes (Video MP4 Format)

O2-10-03 – Leveraging Tissue Specific Gene Expression Regulation to Identify Genes Associated with Alzheimer’s Disease (Video MP4 Format)

O2-10-04 – Mitochondrial Variants and Haplogroups Associated with Late-Onset Alzheimer’s Disease Identified By Whole Exome Sequencing (Video MP4 Format)

O2-10-05 – Meta-Analysis Employing the African Genome Resources Panel Identifies Novel Alzheimer (Video MP4 Format)

O2-10-06 – Genome-Wide Meta-Analysis of Late-Onset Alzheimer’s Disease Using Rare Variant Imputation in 64,859 (Video MP4 Format)

O2-11-01 – Cross-Sectional Associations between CSF Biomarkers of Amyloid and Tau with Neuropsychiatric Symptoms (Video MP4 Format)

O2-11-02 – Neuropsychiatric and Cognitive Symptoms in Alzheimer’s Disease A Study in AD Biomarker Confirmed Patients across the Clinical Spectrum (Video MP4 Format)

O2-11-03 – Behavioral Symptoms Are a Harbinger of Further Cognitive Decline in a 2 Year Longitudinal Study (Video MP4 Format)

O2-11-04 – Towards a Multidimensional Assessment of Apathy in Neurocognitive Disorders (Video MP4 Format)

O2-11-05 – Mild Behavioral Impairment Is Associated with á-Amyloid but Not with Tau in Cognitively (Video MP4 Format)

O2-11-06 – The Course of Apathy in People with Dementia (Video MP4 Format)

O3-01-01 – Interaction between Obesity, Brain HDL, and ApoE4 Genotype in Cerebral Amyloidosis (Video MP4 Format)

O3-01-02 – Chimera Repetitive Mild Traumatic Brain Injury Induces Chronic Behavioral and Neuropathological Phenotypes (Video MP4 Format)

O3-01-04 – Mechanism Securing ‘-Secretase-APP Aá’ Complexes and Regulating Aá Length (Video MP4 Format)

O3-01-05 – Mir-204 Attenuates Memory Deficits in a Mouse Model of Alzheimer’s Disease (Video MP4 Format)

O3-01-06 – Strategy for Development of RNA Aptamers That Target the Toxic Oligomers of Aá42 (Video MP4 Format)

O3-02-01 – Apoe-e4 Allelic Load Modulates the Association between CSF Beta-Amyloid and Gray Matter Volume in Cognitively (Video MP4 Format)

O3-02-02 – Amyloid PET, Tau PET, and MRI Measurements in Cognitively Unimpaired Persons with Two, One, & No Copies of the APOE4 Allele (Video MP4 Format)

O3-02-03 – Association between Apoe Isoform and 18-Month Tau Accumulation (Video MP4 Format)

O3-02-04 – APOE Affect the Network Architecture of the Resting Brain in Individuals at Risk for AD (Video MP4 Format)

O3-02-05 – The Association between Apoe 4 and Age-Related Resting State Functional Connectivity in a Community-Base (Video MP4 Format)

O3-02-06 – Cognitively Normal Apoe-e2 Homozygotes Display Greater Hippocampi An Unbiased Voxel-Based Analysis (Video MP4 Format)

O3-03-01 – The Sequence and Timing of Preclinical Cognitive Decline in Autosomal Dominant Alzheimer’s Disease (Video MP4 Format)

O3-03-03 – Change in Cognition Is Correlated with Change in Brain Volumes in Cognitively Normal Older Adults (Video MP4 Format)

O3-03-04 – Divergent Associations between Life Course Cognitive Trajectories and Brain Pathologies Findings from the 1946 British Birth Cohort (Video MP4 Format)

O3-03-05 – Proper Nouns from Story Recall Are Associated with Beta-Amyloid in Cognitively Unimpaired Adults (Video MP4 Format)

O3-03-06 – Biomarkers and Neuropsychological Measures Differentially Predict Risk of Alzheimer’s Dementia for Men and Women (Video MP4 Format)

O3-04-01 – Biomarkers for Capturing Amyloid Independent Effects of Vascular Health on Cognitive Decline (Video MP4 Format)

O3-04-02 – Microvascular Signature of Preclinical Alzheimer’s Disease in a Longitudinal Cohort (Video MP4 Format)

O3-04-03 – MRI Measures of Neurodegeneration and Vascular Injury, but Not Amyloid Status Predict Cognitive Decline (Video MP4 Format)

O3-04-04 – The Impact of Cerebrovascular Disease on the ATN Profile of Young Cognitively Impaired Patients (Video MP4 Format)

O3-04-05 – Distinctive Effects of Amyloid and Tau on Cognitive Decline According to Cerebrovascular Disease Burden (Video MP4 Format)

O3-04-06 – Comorbid Amyloid-á Pathology Affects Neuropsychiatric, Neuropsychological (Video MP4 Format)

O3-05-01 – Genetic Predisposition, Modifiable Risk Factor Profile, and Long-Term Dementia Risk in the General Population (Video MP4 Format)

O3-05-02 – Current and Past Physical Activity and Risk of Alzheimer’s Disease in Older Adults (Video MP4 Format)

O3-05-03 – The Relationship between Adherence to Australian Dietary Guidelines and Brain Health in Older People with and without Type 2 Diabetes (Video MP4 Format)

O3-05-04 – Associations of the Lifestyle for Brain Health (LIBRA) Index with Structural Brain Changes and Cognition Results (Video MP4 Format)

O3-05-05 – The Prevalence and Attributable Risk of Common Important Risk Factors to Inform Strategies for the Population-Based (Video MP4 Format)

O3-05-06 – Global Council on Brain Health Lifestyle Recommendations for Adults 50+ (Video MP4 Format)

O3-06-01 – NIH Toolbox Cognition Tablet Battery in Identification of Early Cognitive Impairment (Video MP4 Format)

O3-06-02 – Cognitive and Motor Function in Aging Community-Dwelling Individuals The Rotterdam Study (Video MP4 Format)

O3-06-03 – Awareness of Memory Decline in Asymptomatic at Risk for Alzheimer’s Disease The Meta-Memory Ratio. (Video MP4 Format)

O3-06-04 – Evolution and Pathological Basis of Altered Memory Self-Awareness in Cognitively Normal Older Adults (Video MP4 Format)

O3-06-05 – Multiple Memory Tests Substantially Improve Longitudinal Prediction of Progression to Mild Cognitive Impairment (Video MP4 Format)

O3-06-06 – Large-Scale Remote Assessment of Verbal Cognitive Function Using Automatic Speech Recognition. (Video MP4 Format)

O3-07-01 – Transmission of Tauopathy Strains Is Independent of Their Isoform Composition (Video MP4 Format)

O3-07-02 – Lysosomal Dysfunction in Stem Cell Models of Tauopathy (Video MP4 Format)

O3-07-03 – Decreased White Matter Fiber Cross-Section Is Associated to Normal Aging and Higher Tau Deposition Independently of Amyloid (Video MP4 Format)

O3-07-04 – Impaired Neural Code of Spatial Information in a Mouse Model of Tau Pathology (Video MP4 Format)

O3-07-05 – Amyloid-Dependent and Amyloid-Independent Effects of Tau on Clinical Status (Video MP4 Format)

O3-07-06 – In Vivo Network Models Highlight Sex-Specific Differences in the Spread of Tau Pathology across Brain Regions (Video MP4 Format)

O3-08-01 – Phenotypes of Cardiovascular Damage and the Association with Cognitive Decline Among Older Adults A Latent Class Analysis Approach (Video MP4 Format)

O3-08-02 – Cardiovascular Risk Factors across the Lifecourse & Cognitive Decline A Pooled Cohort Study (Video MP4 Format)

O3-08-03 – Unsupervised Machine-Learning for Tracking High Likelihood of Dementia in 9 Population-Based Surveys (Video MP4 Format)

O3-08-04 – A Mediation Analysis of the Relationship between White Matter Hyperintensities, CSF Biomarkers (Video MP4 Format)

O3-08-05 – Lifecourse Work-Family Demands and Late-Life Memory Decline Among U.S. Women (Video MP4 Format)

O3-08-06 – Using Genetic Information to Identify Earliest Manifestations of Alzheimer’s Disease (Video MP4 Format)

O3-09-01 – Protective Effect of Physical Activity on Longitudinal Cognitive Decline (Video MP4 Format)

O3-09-02 – White Matter Hyperintensities in Relation to Patterns of Accelerated Brain Aging (Video MP4 Format)

O3-09-03 – Relationship between Midlife Factors and Multimodal Imaging (Video MP4 Format)

O3-09-04 – Age, á-Amyloid and Cognition Selectively Influence Hippocampal Subfield Volume (Video MP4 Format)

O3-09-06 – Cognitive and Brain Resilience to Tau Pathology in Alzheimer’s Disease (Video MP4 Format)

O3-10-01 – Correlation between Amyloid Reduction and Clinical Outcomes Exploratory Analyses (Video MP4 Format)

O3-10-02 – Verubecestat-Induced Brain Volume Loss Occurs Rapidly and Only in Amyloid-Enriched Brain Regions in EPOCH (Video MP4 Format)

O3-10-03 – The Role of Capillary Angiopathy and Aquaporin 4 in ARIA Induced By Aá Immunization (Video MP4 Format)

O3-10-04 – A Statistical Translation of the Public BAN2401 Study Results from a Bayesian to a Traditional Framework (Video MP4 Format)

O3-10-05 – Modulation of microRNA Pathways By Gemfibrozil in Predementia Alzheimer Disease (Video MP4 Format)

O3-11-01 – Informant Ratings, but Not Self-Reports, of Cognitive Decline Predict Amyloid PET Positivity (Video MP4 Format)

O3-11-02 – Latent Class Analysis Identifies Functional Decline with Amsterdam Iadl in Pre-Clinical Alzheimer’s Disease (Video MP4 Format)

O3-11-03 – Subjective Memory Complaint Is Not Associated with Grey-Matter Volume and Brain Activation (Video MP4 Format)

O3-11-04 – Age-Anchoring SCD to Optimize Its Association with CSF AD Biomarkers (Video MP4 Format)

O3-11-05 – Disentangling the Temporal Sequence of Subjective Cognitive Decline, Depressive Symptoms (Video MP4 Format)

O3-11-06 – Subjective Cognitive Decline in and across International Cohort Studies of Ageing The Cosmic Collaboration (Video MP4 Format)

O3-12-01 – Association between Serum Neurofilament Light and Established White (Video MP4 Format)

O3-12-02 – Plasma Amyloid, Inflammatory Markers, and Time to Dementia in the Ginkgo Evaluation of Memory Study (Video MP4 Format)

O3-12-03 – The CSF Synaptic Biomarker BACE1 Correlates with Cognition in MCI and Alzheirmer Disease (Video MP4 Format)

O3-12-04 – Blood-Based Neuro-Inflammation Biomarkers Differentiate Patterns of Vascular Brain Injury (Video MP4 Format)

O3-12-05 – Increased CSF Soluble TREM2 Is Associated with Ameliorated Longitudinal Cognitive and Clinical Decline (Video MP4 Format)

O3-12-06 – Novel CSF Protein Biomarkers for Specific and Differential Diagnosis of AD. (Video MP4 Format)

O3-13-01 – Highly Penetrant Late-Onset Alzheimer Disease Variants in NOTCH3 in Ashkenazi Jews (Video MP4 Format)

O3-13-02 – Genome-Wide Linkage Analysis of African-American Alzheimer Disease Families (Video MP4 Format)

O3-13-03 – The Role of ZCWPW1 Susceptibility Locus Rare Variants in Alzheimer’s Disease (Video MP4 Format)

O3-13-04 – Genetic Variants in Alzheimer’s Disease-Associated Regions Have Different Effects (Video MP4 Format)

O3-13-05 – Genetic Study of 404 Pedigrees with Familial Alzheimer’s Disease in China (Video MP4 Format)

O3-13-06 – The MS4A Gene Cluster Is a Key Modulator of Soluble TREM2 and Alzheimer Disease Risk (Video MP4 Format)

O3-14-01 – Increased Adherence to Brain-Healthy Behaviors Is Associated with Improved Quality of Life in Older Adults (Video MP4 Format)

O3-14-02 – The Promoting Activity, Independence and Stability in Early Dementia (PrAISED) Research Programme (Video MP4 Format)

O3-14-03 – A Scoping Review of Behaviour Change Theories in Adults without Dementia to Develop (Video MP4 Format)

O3-14-04 – A Pilot Cluster RCT to Test the Preliminary Efficacy of an Alzheimer’s Family Caregiver Intervention in Hanoi, Vietnam (Video MP4 Format)

O3-14-05 – Our Family Journey Program- an Evidence-Based, Skills Building Mental Health (Video MP4 Format)

O4-01-01 – Inhibiting Amyloid-Beta Cytotoxicity through Its Interaction with the Cell (Video MP4 Format)

O4-01-02 – Structure Based Inhibitors of Amyloid Beta Core Suggest a Common Interface with Tau (Video MP4 Format)

O4-01-03 – Mechanisms of Inhibitors That Block Seeding By Tau from Human Tauopathies (Video MP4 Format)

O4-01-04 – Polymorphism and Toxic Interactions between Soluble Amyloid Oligomers and Tau (Video MP4 Format)

O4-01-05 – Comparative Prionoid and Strain Properties of Tau and Synuclein (Video MP4 Format)

O4-01-06 – Secernin-1 Is a Novel Phosphorylated Tau Binding Protein That Accumulates in Alzheimer’s Disease (Video MP4 Format)

O4-02-01 – Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial (Video MP4 Format)

O4-02-02 – What Are the Effects of Benzodiazepine and Anticholinergic Drug Use on the Brain- Neuropathological Study (Video MP4 Format)

O4-02-03 – Randomized Trial of Suvorexant for Treating Insomnia in Alzheimer’s Disease Effects on Objective Sleep Measures (Video MP4 Format)

O4-02-04 – Exploring Gut Microbiota As a Source of Potential Biomarkers Initial Results from the Anavex (Video MP4 Format)

O4-02-05 – Continued Innovations in Study Start up (SSU)Ongoing Progress of the GAP Foundation on Site Start up (Video MP4 Format)

O4-02-06 – Oral Treatment with RD2 Reduces AB Oligomer Load, Enhances Cognition, Decelerates (Video MP4 Format)

O4-03-01 – Frontotemporal Lobar Degeneration Research in North AmericaProgress in the ArtflLefftds Consortia (Video MP4 Format)

O4-03-02 – Differentiating Frontotemporal Dementia from Alzheimer’s Disease on Measures of Empathy (Video MP4 Format)

O4-03-03 – Clinical Characterization of Mild Cognitive Impairment Associated with Eventual Lewy Body Disease Pathology (Video MP4 Format)

O4-03-04 – Profile of and Risk Factors for Post-Stroke Cognitive Impairment in Diverse Ethno-Regional Groups (Video MP4 Format)

O4-03-05 – Longitudinal Cognitive Decline and Prodromal Staging Model for Alzheimer’s Disease in Down Syndrome (Video MP4 Format)

O4-03-06 – Longitudinal Association between Apathy and Cognitive Decline (Video MP4 Format)

O4-04-01 – What Can Structural MRI Tell about aTN Staging (Video MP4 Format)

O4-04-02 – Identification of Fast Converters Among MCI Patients By Integrating Incomplete (Video MP4 Format)

O4-04-03 – The Biological Basis of Cognitive Impairment Due (Video MP4 Format)

O4-04-04 – Pib(+) Chronicity Provides Unique Information about Cognitive Decline and NFT Development (Video MP4 Format)

O4-04-05 – Microglial Activation and Tau Burden Predict Cognitive Decline in Alzheimer’s Disease (Video MP4 Format)

O4-04-06 – Amyloid PET Is More Than Just Positive or Negative Amyloid Level Impacts Risk of Clinical Progression in Normal Individuals. (Video MP4 Format)

O4-05-01 – Apolipoprotein e4 Allele Effects on Longitudinal Cognitive Trajectories Are Sex- and Age-Dependent (Video MP4 Format)

O4-05-02 – Does the Effect of Education on Cognition Differ across RacialEthnic Groups Evidence from the Kaiser Healthy Aging (Video MP4 Format)

O4-05-03 – A Longitudinal Study of the Effects of Education and Intracranial Volume (Video MP4 Format)

O4-05-04 – Subclinical Cardiovascular Dysfunction Is Associated with Increased Cerebrospinal Fluid … (Video MP4 Format)

O4-05-05 – Social Support and Cognitive Function in Type 1 Diabetes Findings from the Study of Longevity in Diabetes (SOLID) Study (Video MP4 Format)

O4-05-06 – Invariance Measurement of Neuropsychological Tests across Different Sociodemographic Background (Video MP4 Format)

O4-06-02 – Fitness for the Ageing Brain Study (FABS) Long-Term Follow-up Stage 1 (Video MP4 Format)

O4-06-03 – Exploring Individual Variability in Exercise-Induced Cognitive Change (Video MP4 Format)

O4-06-04 – Precision Medicine Intervention in Patients at Risk for Alzheimer’s Dementia (Video MP4 Format)

O4-06-05 – Promoting a Brain-Healthy Lifestyle for Reducing the Risk of Cognitive Decline and Dementia Libra and the Mijnbreincoach (Video MP4 Format)

O4-06-06 – An Evaluation of the Implementation of Mybrainrobbie in School-Age Children in France (Video MP4 Format)

O4-07-01 – Trends in Dementia Prevalence, Incidence and Mortality in the United States (Video MP4 Format)

O4-07-02 – Trends in Incident Dementia and Early Life Environment By Birth Cohort (Video MP4 Format)

O4-07-03 – Birth Cohort Analysis of Trends in Amnestic Mild Cognitive Impairment (MCI) (Video MP4 Format)

O4-07-04 – Subjective Cognitive Decline Higher Among Sexual and Gender Minorities Population-Based Findings from Nine States in the U.S. (Video MP4 Format)

O4-07-05 – NIA-AA Research Framework Application to the French Population By Inference from the Memento Cohort (Video MP4 Format)

O4-08-01 – Unmet Needs Among Americans Living Alone with Dementia A Population-Based Study (Video MP4 Format)

O4-08-02 – Priorities and Concerns of Older Latinos Living Alone with Cognitive Impairment An in-Depth Perspective (Video MP4 Format)

O4-08-03 – Village Infrastructure, Community Facilities and Its Effect on Cognitive Function Among Older Adults in Rural China Evidence from the Baseline (Video MP4 Format)

O4-08-04 – Where Do I Fit in the Impact of Gentrification on Aging in Place (Video MP4 Format)

O4-08-05 – Well-Being and Quality of Life in Mild Cognitive Impairment The Influence of Social Networks, Loneliness and Spirituality (Video MP4 Format)

O4-08-06 – Neighborhood Park Space and Cognition in Non-Demented Older Adults The Multi-Ethnic Study of Atherosclerosis (Video MP4 Format)

O4-09-01 – Leveraging Mouse Genetic Diversity to Investigate the Role of Brain Myeloid Cells in Alzheimer’s Disease (Video MP4 Format)

O4-09-02 – Regulation of Pro-Inflammatory and Disease-Associated Microglial Activation By Bin1 (Video MP4 Format)

O4-09-03 – Immunosuppression Exacerbates Alzheimer’s Disease Pathology in APP PS1 Transgenic Mice (Video MP4 Format)

O4-09-04 – Upregulation of SOCS3 By Aspirin in Brain Cells Via PPAR-Alpha (Video MP4 Format)

O4-09-05 – Inteleukin-10 Induces Metabolic Changes Driving Aá Immune Tolerance in Macrophages (Video MP4 Format)

O4-09-06 – Clonally Expanded CD8 T Cells Patrol Alzheimer’s Cerebrospinal Fluid (Video MP4 Format)

O4-10-01 – Characterizing Cell Type-Specific Expression Signatures in Brain Using Single Cell RNA Sequencing (Video MP4 Format)

O4-10-02 – Dysregulated Fc Gamma R-Mediated Phagocytosis Pathway in Alzheimer’s Disease Network-Based Gene Expression Analysis (Video MP4 Format)

O4-10-03 – Functional Dissection of Alzheimer’s Disease Brain Gene Expression Signatures in Humans and Mouse Models (Video MP4 Format)

O4-10-04 – Large-Scale Proteomic Analysis of Human Prefrontal Cortex Identifies Proteins Associated with Cognitive Trajectory in Advanced Age (Video MP4 Format)

O4-10-05 – Multi-Omic Analysis Identifies Transcriptional Networks and Drivers Associated with Cognitive Aging and Alzheimer’s Disease (Video MP4 Format)

O4-10-06 – Integrated Genetic-Epigenetic Analyses of Alzheimer’s Disease (Video MP4 Format)

O4-11-01 – World Wide Fingers A Global Collaboration for Future Generations (Video MP4 Format)

O4-11-02 – NSAIDs for AD Prevention Naproxen Enters the CNS without Apparent Effect on CSF Immune Markers (Video MP4 Format)

O4-11-03 – U.S. Pointer Study Design and Launch (Video MP4 Format)

O4-11-04 – Linking Diabetes and Alzheimer’s Disease through RAGE. a Retrospective Analysis of Azeliragon Phase 2 and Phase 3 Studies (Video MP4 Format)

O4-11-05 – A Proof of Concept Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment Evidence (Video MP4 Format)

O4-11-06 – Defining Cognition in Pre-Dementia Clinical Trials Baseline Neuropsychological Data from the TOMMORROW Study (Video MP4 Format)

O4-12-01 – Tau PET Imaging Correlates with Neuropathology (Video MP4 Format)

O4-12-02 – Tau Pathology and Cognition Are Related to Basal Forebrain Degeneration in Aging (Video MP4 Format)

O4-12-03 – Cortical Tau Deposition Follows Patterns of Entorhinal Functional Connectivity in Cognitively Normal Older Adults (Video MP4 Format)

O4-12-04 – Cerebrospinal Fluid and PET Measures of Tau Pathology Indicate Different State of AD Pathophysiological Progression (Video MP4 Format)

O4-12-05 – Evaluation of Tau Deposition in Amyloid Positive MCI or Mild-AD Dementia Subjects from the Elenbecestat Mission AD Program (Video MP4 Format)

O4-12-06 – Automated Reporting of Tau PET Quantification on Brain Surface (Video MP4 Format)

O4-13-01 – Early Adulthood Vascular Risk Strongly Predicts Brain Volumes and White Matter Disease, but Not Amyloid Status, at Age 69-71 Year (Video MP4 Format)

O4-13-02 – Mid- and Late-Life Physical Activity and Brain Amyloid Deposition The Atherosclerosis Risk in Communities (ARIC)-PET Study (Video MP4 Format)

O4-13-03 – Plasma Amyloid-á Monomers and the Risk of Clinical Cardiovascular Disease in the General Population The Rotterdam Study (Video MP4 Format)

O4-13-04 – The Association between Particulate Matter and Episodic Memory Decline Is Partially Mediated By Early Neuroanatomic Biomarkers (Video MP4 Format)

O4-13-05 – Brain Correlates of Air Pollution in Cognitively Healthy Individuals at Risk of Alzheimer’s Disease (Video MP4 Format)

O4-13-06 – Associations between Multimorbidity and CSF Amyloid Cross-Sectional Analysis of the European Prevention of Alzheimer’s Dementia (Video MP4 Format)

O5-01-01 – Head-to-Head In Vivo Comparison of Tau Positron Emission Tomography Ligands 18f-Flortaucipir and 18f-RO948 (Video MP4 Format)

O5-01-02 – Functional Brain Architecture Predicts Longitudinal Tau Spreading in Alzheimer’s Disease (Video MP4 Format)

O5-01-03 – Early Tau PET Pathology Is Associated with Memory Performance in Cognitively Unimpaired Individuals with SCD The Science Project (Video MP4 Format)

O5-01-04 – Patterns of Tau Pathology Identified with 18f-MK-6240 PET Imaging (Video MP4 Format)

O5-01-05 – Tau Imaging with 18f-MK6240 in Alzheimer’s Disease and Other Dementias (Video MP4 Format)

O5-01-06 – Early Tau Detection and Implications for Disease Progression (Video MP4 Format)

O5-02-01 – Genome-Wide Association Study of Plasma Tau Levels Using Hrc Imputations in the Framingham Study (Video MP4 Format)

O5-02-02 – Differential Expression of Polygenic Risk in Cerebrospinal Fluid Proteomic Measures in Alzheimer’s Disease (Video MP4 Format)

O5-02-03 – Onset Age Modifier for GRN-Associated Frontotemporal Lobar Degeneration (Video MP4 Format)

O5-02-04 – Integrative Genomic Profiling to Identify Genes and Pathways Associated with Vascular Risk in AD. (Video MP4 Format)

O5-02-05 – Genome-Wide, Stage-Specific Association across Alzheimer’s Disease Endophenotypes Modeling SNP By Diagnosis Interactions (Video MP4 Format)

O5-02-06 – Genetic Association and Characterization of CCRL2-V180M with Alzheimer’s Disease, Cognitive Decline, and Serum Cytokine Levels. (Video MP4 Format)

O5-03-01 – Affordable EEG Markers for the Screening of Cognitive Impairment of Old Adults (Video MP4 Format)

O5-03-02 – Electroretinography in Pre-Clinical Alzheimer’s Disease An Electrophysiologic Assessment of the Retina As an Early Detection Ocular (Video MP4 Format)

O5-03-03 – The Subclinical-Clinical Spectrum of Hyperexcitability in Alzheimer’s Disease An Ambulatory Scalp EEG Study (Video MP4 Format)

O5-03-04 – Abnormalities of Electroencephalographic (EEG) Markers in Quiet Wakefulness Are Related to Motor Deficits, Cognitive Symptoms (Video MP4 Format)

O5-03-05 – Retinal Nerve Fiber Layer Thinning in Pre-Clinical Alzheimer’s Disease Predicts CSF Amyloid Tau Classification (Video MP4 Format)

O5-03-06 – Do Odor Identification and Remote Odor Memory Together Predict Conversion from MCI to AD in ApoE e4 Carriers (Video MP4 Format)

O5-04-01 – TRIM46 Knockdown Causes Neuronal Tau Redistribution and Increases Axosomatic Tau Diffusion (Video MP4 Format)

O5-04-02 – Traumatic Brain Injury Induces Tau Aggregation and Spreading (Video MP4 Format)

O5-04-03 – Relevance of Tau Seeding for the Clinical Heterogeneity of Alzheimer’s Disease, Implication for Therapeutic Perspectives (Video MP4 Format)

O5-04-04 – Accumulation of Modifications in the Tau Core Region during the Tau Aggregation Process in Alzheimer’s Disease (Video MP4 Format)

O5-04-05 – A New Therapeutic Strategy for Tauopathies- Discovery of Highly Potent Brain Penetrant PROTACTM Degrader Molecules That Target (Video MP4 Format)

O5-04-06 – Tau Associates with Ribosomal Proteins Shifting the Translatome (Video MP4 Format)

O5-05-01 – Multivariate Patterns of Association between Diffusion Imaging Metrics and Plasma Neurofilament Light in Prodromal Alzheimer’s Disease (Video MP4 Format)

O5-05-02 – CSF Biomarkers of Synaptic Damage (Neurogranin, SNAP25) and Interneuron-Dependent Synaptic Homeostasis (NPTX2)I (Video MP4 Format)

O5-05-03 – Associations between Cerebrospinal Fluid Neurodegenerative Markers Neurofilament-Light and Total Tau and Cerebrovascular Imaging Markers (Video MP4 Format)

O5-05-04 – Plasma Neurofilament Light Measurements in More Than 2,100 Presenilin-1 E280A Mutation Carriers and Non-Carriers from the World’s (Video MP4 Format)

O5-05-05 – Undulations of the Plasma Proteome Define Distinct Stages of Human Lifespan and Reveal Accelerated Aging in Alzheimer’s Disease (Video MP4 Format)

O5-06-01 – Selective Targeting of Amyloid-Beta Oligomer Species By PMN310, a Monoclonal Antibody Rationally Designed for Greater Therapeutic Potency (Video MP4 Format)

O5-06-02 – Axonal Organization Defects in the Hippocampus of Adult Conditional BACE1 Knockout Mice Implications for BACE1 Inhibitor Clinical Trials (Video MP4 Format)

O5-06-03 – Small Molecules Targeting Tau Aggregation Decrease Tau Pathology and Neuroinflammation In Vivo (Video MP4 Format)

O5-06-04 – Characterization of Novel Tau-Specific Antibodies and Enhancement of Their Delivery into the Brain Using Focused Scanning Ultrasound (Video MP4 Format)

O5-06-05 – Improved Intrathecal Vector Delivery for Gene Therapy in Alzheimer’s Disease (Video MP4 Format)

O5-06-06 – Ligands of the Core Acetylcholine Biosynthesizing Enzyme, Choline Acetyltransferase As Novel and Potential Therapeutic Agents (Video MP4 Format)

O5-07-01 – Global Cortical [F18]Flortaucipir Association with the Top 20 Alzheimer’s Disease Risk Genes (Video MP4 Format)

O5-07-02 – Apolipoprotein E and BIN1 Polymorphisms Differentially Affect Cortical Amyloid and Tau Load in Healthy Older Adults (Video MP4 Format)

O5-07-03 – Integrating Genetics and Brain Imaging to Improve Alzheimer’s Disease Risk Prediction (Video MP4 Format)

O5-07-04 – Combining Omics and Imaging Data from the Insight Pre-AD Study, Artificial Intelligence Technology Identifies Genomic (Video MP4 Format)

O5-07-05 – GWAS of Hippocampal Subfield and Neighboring Cortical Structure Volumes Identifies an ERC1 Locus Using ADNI High-Resolution MRI Data (Video MP4 Format)

O5-07-06 – The Heritability of Amyloid Deposition and Its Shared Genetic Basis with Small Vessel Disease in the Brains of Older People (Video MP4 Format)

O5-08-01 – Trends in Racial and Ethnic Differences in Dementia Prevalence Rates and Disease Awareness (Video MP4 Format)

O5-08-02 – Costs of Alzheimer’s Disease and Dementia in 188 Countries (Video MP4 Format)

O5-08-03 – Trajectories of Health System Use and Survival for Community-Dwelling Persons with Dementia An Inception Cohort Study (Video MP4 Format)

O5-08-04 – A New Open-Source Modeling Framework to Assess Cost Effectiveness of Early Intervention in Alzheimer’s Disease. (Video MP4 Format)

O5-08-05 – Structural Uncertainty and Cross-Validation of Decision Models in the AD Setting Answering Questions from Policy Makers on the Reliability (Video MP4 Format)

O5-08-06 – Cost-Effectiveness of a Collaborative Dementia Care Management – Results of a Cluster-Randomized Controlled Trial (Video MP4 Format)

O5-09-01 – Gender Differences in Mental Status Trajectories across Adulthood Are Men More Resilient Than Women (Video MP4 Format)

O5-09-02 – Duration of Dementia and Formal Care Use Effects of Age, Gender, Living Situation, Dementia Medication and Ethnicity (Video MP4 Format)

O5-09-03 – Sex Differences in Dementia Evidence from Population-Based Studies and the Finger Lifestyle Intervention (Video MP4 Format)

O5-09-04 – Validity of Algorithmic Diagnoses of Dementia A Case Study of Application to Research on Race Ethnic Disparities in Dementia (Video MP4 Format)

O5-09-05 – Racial and Ethnic Differences in Dementia Diagnosis Following Cognitive Decline Insights from Linked Survey and Health Care Claims Data (Video MP4 Format)

O5-09-06 – Race Modifies the Association between Sleep Disturbance, Cognitive Decline and Alzheimer’s Disease Biomarkers Among Cognitively (Video MP4 Format)

O5-10-01 – Enhanced Function of PLCg2 Variant P522R in Macrophages and Microglia Is Associated with Protection from Alzheimer’s Disease (Video MP4 Format)

O5-10-02 – The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (Video MP4 Format)

O5-10-03 – Mapping Genome Repair Hotspots in Post-Mitotic Human Neurons (Video MP4 Format)

O5-10-04 – Dysregulation of NSUN2 Promotes Pathological Tau Alterations in Alzheimer’s Disease (Video MP4 Format)

O5-10-05 – Novel Insights of Tau RNA-Protein Biology in the Precipitating Role of Chronic Stress on Alzheimer’s Disease Brain Pathology. (Video MP4 Format)

O5-10-06 – Loss of Neuroprotective MiR-219 Reveals a Dysregulated Tau Kinase Network in Alzheimer’s Disease (Video MP4 Format)

PL-01-01 – Plenary Session Association Welcome (Video MP4 Format)

PL-01-02-01 – Understanding the Earliest Phases of Alzheimer’s Disease (Video MP4 Format)

PL-03-01 – Plenary Session Inge Grundke-Iqbal Award for Alzheimer’s Research Neurotoxic Reactive Astrocytes Are Induced (Video MP4 Format)

PL-04-01-01 – Imaging Neurodegeneration with MRI What Is New (Video MP4 Format)

PL-04-02-01 – The Cellular Phase of Alzheimer’s Disease (Video MP4 Format)

S1-01-01 – Dementia Prevention Programs in Urban and Regional Aboriginal Communities in Australia (Video MP4 Format)

S1-01-02 – Health Literacy and Access to Dementia Care (Video MP4 Format)

S1-01-03 – Improving the Lives of People with Dementia The OECD Perspective (Video MP4 Format)

S1-01-04 – Dementia As Access Barrier in Palliative Care (Video MP4 Format)

S1-02-01 – Clustering of Rare Variants in Alzheimer Disease and Related Disorders in the Colombian Population A Genomic Study (Video MP4 Format)

S1-02-02 – The Potential Contribution of Rare Variants to Neurodegenerative Brain Dementia (Video MP4 Format)

S1-02-03 – Whole-Exome Sequencing in 20,197 Persons for Rare Variants in Alzheimer’s Disease (Video MP4 Format)

S1-02-04 – High-Throughput Identification of Noncoding Functional SNPs (Video MP4 Format)

S2-01-01 – PET Markers of Microglia (Video MP4 Format)

S2-01-02 – PET Markers of Astrocytes (Video MP4 Format)

S2-01-03 – Neuroinflammation CSF Perspective (Video MP4 Format)

S2-01-04 – Fluid Biomarkers of Neuroinflammation (Video MP4 Format)

S2-02-01 – Precision Medicine Model for Targeted NSAID Therapy in AD (Video MP4 Format)

S2-02-03 – Insulin-Resistant Sub-Typing (Video MP4 Format)

S2-02-04 – Subtyping of Clinical Subjects through Exosome Analyses (Video MP4 Format)

S3-01-01 – Alzheimer’s and Vascular Disease A Pathobiological Perspective (Video MP4 Format)

S3-01-02 – Alzheimer’s Disease and Subcortical Vascular Cognitive Impairment (SVCI) Biomarker Perspective (Video MP4 Format)

S3-01-03 – Alzheimer’s and Lewy Body Disease Pathologic Perspective (Video MP4 Format)

S3-01-04 – Alzheimer’s and Lewy Body Disease Biomarker Perspective (Video MP4 Format)

S3-02-01 – Statistical Challenges with Responder Analysis in Exploratory Settings (Video MP4 Format)

S3-02-02 – Multi-Crossover Randomized Control Design Approaches Based on Analyses of ResponderNon-Responder Outcomes (Video MP4 Format)

S3-02-03 – Statistical Considerations for Efficient Designs within a Platform Trial Approach (Video MP4 Format)

S3-02-04 – Determining Whether Identification of a Responder Sub-Group is Truly Hypothesis Generating (Video MP4 Format)

S4-01-01 – ?Identifying Elders at risk for Cognitive Decline using the Brain Health Registry BHR (Video MP4 Format)

S4-01-02 – The Dutch Brain Health Registry for Recruitment of Research Participants (Video MP4 Format)

S4-01-03 – Swedish Clinical Quality Registry for Dementia (Video MP4 Format)

S4-01-04 – The Australian Dementia Network (ADNet) Clinical Quality Registry (Video MP4 Format)

S5-01-01 – Description and Impact of Delirium on Dementia (Video MP4 Format)

S5-01-01 – Immunotherapy in Alzheimer Disease Mechanisms of Monoclonal Antibodies in Development (Video MP4 Format)

S5-01-02 – Biomarkers in Delirium (Video MP4 Format)

S5-01-03 – Neurobiology of Delirium and Its Intersection with Dementia Insights from Animal Models (Video MP4 Format)

S5-01-04 – Systemic Inflammation Signaling to the Brain (Video MP4 Format)

TD-03-01 – Gait Impairments in Dementia Subtypes Considering the Impact of Environmental Context (Video MP4 Format)

TD-03-03 – Developing an Electronic Consent for ADRC (Video MP4 Format)

TD-03-04 – High Compliance, Continuous Long-Term Home Monitoring of Sleep Activity in Diverse Populations (Video MP4 Format)

TD-04-01 – Mobile Monitoring of Cognition in Middle-Aged and Older Adults with and without Amnestic Mild Cognitive Impairment (Video MP4 Format)

TD-04-04 – Augmented Reality Technology for People with Dementia (Video MP4 Format)

TD-04-05 – A Cross-Comparison and Validation of Four Computer-Administered Neuropsychological Assessment (Video MP4 Format)

TD-04-06 – Gamechanger Can Digital Biomarkers Transform the Detection of Preclinical Alzheimer’s Disease (Video MP4 Format)

TD-04-07 – Identifying Prodromal Features of Dementia in UK Primary Care A Nested Case-Control Study (Video MP4 Format)

TD-04-08 – GENFI Ignite A Novel Cognitive Assessment App for Testing Presymptomatic Frontotemporal Dementia (Video MP4 Format)

TD-04-09 – AI-Based Digital Phenotyping of Behavioral and Psychiatric Symptoms in Dementia Clinical Implications (Video MP4 Format)

TD-04-10 – Development and Usability of ADappt – an Online Tool to Support Clinicians, Patients and Caregivers (Video MP4 Format)

TD-04-11 – Delivering Disease Progression Models to Clinical Practice A User Study on Opportunities and Barriers for Translation and Adoption (Video MP4 Format)

TD-04-12 – Identifying Individuals with Dementia, MCI and Physical Impairment during Group Activities (Video MP4 Format)

TD-04-13 – Using Participatory Design & Community Engagement to Develop Online Caregiver Support (Video MP4 Format)

TD-04-14 – The Challenges of Monitoring Subject Adherence to Study Protocols in Technology-Based Aging and Dementia Clinical Research Studies (Video MP4 Format)

TD-04-15 – Unobtrusive, Sensor-Based Measurement of in-Home Walking Speed and Its Day-to-Day Variability Identifies Future Falls in Older Adults (Video MP4 Format)

Contact Us
Do you have any questions or need support? feel free to ask and we will help you with it